ArticleBMC surgery2025

Prediction of surgical resectability after FOLFIRINOX chemotherapy for borderline resectable and locally advanced pancreatic cancer (PeRFormanCe): a multicenter prospective trial - trial protocol.

Luís Filipe Abreu de Carvalho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.